Key result
STK39 polymorphisms were not significantly associated with systolic or diastolic blood pressure in a British Caucasian cohort, despite demonstrating cis-acting influences on gene expression in vivo.
Why the study?
Do STK39 polymorphisms influence blood pressure or gene expression in vivo?
Observational (n=1,372)
Yes
Do STK39 polymorphisms influence blood pressure or gene expression in vivo?
STK39 polymorphisms modify gene expression in vivo but are not associated with blood pressure in a British Caucasian cohort, challenging previous findings in other populations.
Answers are grounded in this paper and cite their sources.
STK39 variants should not yet inform BP risk assessment in Caucasians; leaves open population-specific links between expression and blood pressure.
BACKGROUND: Blood pressure (BP) has significant heritability, but the genes responsible remain largely unknown. Single nucleotide polymorphisms (SNPs) at the STK39 locus were recently associated with hypertension by genome-wide association in an Amish population; in vitro data from transient transfection experiments using reporter constructs suggested that altered STK39 expression might mediate the effect. However, other large studies have not implicated STK39 in hypertension. We determined whether reported SNPs influenced STK39 expression in vivo, or were associated with BP in a large British Caucasian cohort. METHODS: 1372 members of 247 Caucasian families ascertained through a hypertensive proband were genotyped for reported risk variants in STK39 (rs6749447, rs3754777, rs35929607) using Sequenom technology. MERLIN software was used for family-based association testing. Cis-acting influences on expression were assessed in vivo using allelic expression ratios in cDNA from peripheral blood cells in 35 South African individuals heterozygous for a transcribed SNP in STK39 (rs1061471) and quantified by mass spectrometry (Sequenom). RESULTS: No significant association was seen between the SNPs tested and systolic or diastolic BP in clinic or ambulatory measurements (all p > 0.05). The tested SNPs were all associated with allelic expression differences in peripheral blood cells (p < 0.05), with the most significant association for the intronic SNP rs6749447 (P = 9.9 x 10-4). In individuals who were heterozygous for this SNP, on average the G allele showed 13% overexpression compared to the T allele. CONCLUSIONS: STK39 expression is modified by polymorphisms acting in cis and the typed SNPs are associated with allelic expression of this gene, but there is no evidence for an association with BP in a British Caucasian cohort.
No takes yet. Share an insight, caveat, or question.
Cunnington et al. (2009) conducted an observational in Essential Hypertension (n=1,372). STK39 polymorphisms (rs6749447, rs3754777, rs35929607) vs. Alternative alleles was evaluated on Association between STK39 SNPs and systolic or diastolic blood pressure (p=>0.05). STK39 polymorphisms were not significantly associated with systolic or diastolic blood pressure in a British Caucasian cohort, despite demonstrating cis-acting influences on gene expression in vivo.
Synapse has enriched 10 related papers. Consider them for comparative context: